1. Home
  2. AVBP vs INOD Comparison

AVBP vs INOD Comparison

Compare AVBP & INOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVBP
  • INOD
  • Stock Information
  • Founded
  • AVBP 2021
  • INOD 1988
  • Country
  • AVBP United States
  • INOD United States
  • Employees
  • AVBP N/A
  • INOD N/A
  • Industry
  • AVBP
  • INOD EDP Services
  • Sector
  • AVBP
  • INOD Technology
  • Exchange
  • AVBP NYSE
  • INOD Nasdaq
  • Market Cap
  • AVBP 980.3M
  • INOD 1.1B
  • IPO Year
  • AVBP 2024
  • INOD 1993
  • Fundamental
  • Price
  • AVBP $27.81
  • INOD $38.26
  • Analyst Decision
  • AVBP Strong Buy
  • INOD Strong Buy
  • Analyst Count
  • AVBP 5
  • INOD 4
  • Target Price
  • AVBP $37.40
  • INOD $36.50
  • AVG Volume (30 Days)
  • AVBP 140.3K
  • INOD 1.3M
  • Earning Date
  • AVBP 02-10-2025
  • INOD 02-20-2025
  • Dividend Yield
  • AVBP N/A
  • INOD N/A
  • EPS Growth
  • AVBP N/A
  • INOD N/A
  • EPS
  • AVBP N/A
  • INOD 0.62
  • Revenue
  • AVBP N/A
  • INOD $137,393,000.00
  • Revenue This Year
  • AVBP N/A
  • INOD $93.11
  • Revenue Next Year
  • AVBP N/A
  • INOD $34.30
  • P/E Ratio
  • AVBP N/A
  • INOD $62.36
  • Revenue Growth
  • AVBP N/A
  • INOD 71.66
  • 52 Week Low
  • AVBP $14.35
  • INOD $5.46
  • 52 Week High
  • AVBP $36.37
  • INOD $55.17
  • Technical
  • Relative Strength Index (RSI)
  • AVBP 53.46
  • INOD 48.14
  • Support Level
  • AVBP $25.90
  • INOD $32.58
  • Resistance Level
  • AVBP $29.71
  • INOD $38.89
  • Average True Range (ATR)
  • AVBP 1.49
  • INOD 2.34
  • MACD
  • AVBP 0.25
  • INOD -0.11
  • Stochastic Oscillator
  • AVBP 67.85
  • INOD 46.79

About AVBP ARRIVENT BIOPHARMA INC

ArriVent BioPharma Inc is a clinical stage biopharmaceutical company dedicated to the identification, development and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers. It seeks to utilize team's deep drug development experience to maximize the potential of lead development candidate, furmonertinib, and advance a pipeline of novel therapeutics, such as next-generation antibody drug conjugates, through approval and commercialization in patients suffering from cancer, with an initial focus on solid tumors.

About INOD Innodata Inc.

Innodata Inc is a digital services and solutions company. It provides technology and services to information products and online retail destinations. The company has three operating segments: Digital data solutions, Synodex, and Agility. It serves publishers, media and information companies, digital retailers, banks, insurance companies, government agencies, and other industries. Geographically, it operates in the United States, United Kingdom, Netherlands, Canada, and Europe.

Share on Social Networks: